Biocrates To Provide Metabolomics Services for EU Cancer Biomarker Study | GenomeWeb

Biocrates To Provide Metabolomics Services for EU Cancer Biomarker Study

May 10, 2007

NEW YORK (GenomeWeb News) - Biocrates Life Sciences has joined a European Union project to find diagnostic biomarkers for colon and breast cancer, the company said today.

Biocrates, based in Innsbruck, Austria, said that it will perform metabolomics services for the study, called COBRED for Colon and Breast cancer Diagnostics.

The company said it will use its TargetIDQ metabolomics platform to identify and quantify more than 1,000 metabolites in the study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.